Bevacizumab,Durvalumab,Olaparib,Carboplatin,Paclitaxel
AstraZeneca,roche,Merck
['olaparib', 'durva', 'gyn', 'ovarian']
addition of up-front durvalumab, maintenance olaparib to standard therapy improves pfs in advanced ovarian cancer #asco23 #asco2023 #gyncsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.